Drug
CLA
CLA is a pharmaceutical drug with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_2
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
NCT02188368
completednot_applicable
Conjugated Linoleic Acid in Obese Women
NCT02529046
completednot_applicable
Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease
NCT00942656
Clinical Trials (3)
Showing 3 of 3 trials
NCT02188368Phase 2
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
NCT02529046Not Applicable
Conjugated Linoleic Acid in Obese Women
NCT00942656Not Applicable
Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3